[Effect of the fibrinolytic system in experimental atheromatosis].
D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000097:blood* / Q000209:etiology / Q000473:pathology; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage*; D004036:Diet, Atherogenic; D010450:Endopeptidases / Q000008:administration & dosage*; D005342:Fibrinolysis / Q000187:drug effects*; D008297:Male; D011817:Rabbits; D014148:Tranexamic Acid / Q000008:administration & dosage*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator
Influencia del sistema fibrinolítico en la ateromatosis experimental.